Diseases & Disorders
(G30)
990 on File
EVERLASTING HOPE CHILDHOOD CANCER MISSION
Financial strength (30%)
75/100
Reliability (20%)
45/100
Effectiveness (25%)
61/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$139K
Total Revenue
$155K
Total Expenses
$6K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
79.1%
Fundraising Efficiency
0.0%
Operating Reserve
0.45x
Liability-to-Asset
0.0%
Revenue Diversification
99.6%
Compared with Peers
FY 2024
Compared with 1,541 similar organizations
(United States, Diseases & Disorders, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
79.1% | 83.1% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
0.0% | 19.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
0.5 mo | 12.0 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.7% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.6% | 93.9% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
31.1% | 7.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
55.5% | 9.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-11.4% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $139K | $155K | $6K | 79.1% | — |
| 2023 | $106K | $99K | $62K | 70.2% | — |
| 2022 | $175K | $135K | $56K | 76.6% | — |
| 2021 | $182K | $81K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.